Q3 2024 · 13F-HR
Redmile Group, LLCholdings as filed
Filed 2024-11-14 · accession 0001104659-24-118934
$1.70B
Reported value
63
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $147.5M | 8.69% | 810,245 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $96.2M | 5.67% | 4,280,981 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $88.1M | 5.19% | 8,246,592 | Common | SOLE |
| 45257U108 | IMNM | IMMUNOME INC | $71.5M | 4.21% | 4,889,554 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $65.9M | 3.88% | 1,393,256 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $64.0M | 3.77% | 5,101,911 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $57.9M | 3.41% | 4,713,509 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $52.4M | 3.09% | 4,781,183 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $51.7M | 3.04% | 1,034,219 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $51.3M | 3.02% | 4,892,902 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $50.8M | 2.99% | 3,072,478 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $49.4M | 2.91% | 15,669,217 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $48.4M | 2.85% | 4,484,380 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $46.1M | 2.72% | 13,169,057 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $46.0M | 2.71% | 875,039 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $42.0M | 2.47% | 5,238,837 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $40.5M | 2.38% | 964,347 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $39.8M | 2.35% | 1,387,479 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $39.5M | 2.33% | 1,611,013 | Common | SOLE |
| 05105P107 | AUGX | AUGMEDIX INC | $38.5M | 2.27% | 16,380,327 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $38.1M | 2.24% | 6,427,462 | Common | SOLE |
| 148806102 | CTLTEUR | CATALENT INC | $36.1M | 2.13% | 595,570 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $35.8M | 2.11% | 3,197,491 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $34.5M | 2.03% | 1,899,317 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $32.1M | 1.89% | 552,506 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $31.5M | 1.86% | 8,253,316 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $27.7M | 1.63% | 330,873 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $22.3M | 1.32% | 657,175 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $21.6M | 1.27% | 681,150 | Common | SOLE |
| 82024L103 | STTK | SHATTUCK LABS INC | $19.6M | 1.15% | 5,615,489 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $18.3M | 1.08% | 154,456 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $18.3M | 1.08% | 642,229 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $13.6M | 0.80% | 1,262,090 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $13.1M | 0.77% | 26,698 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $11.8M | 0.70% | 32,741 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $11.6M | 0.68% | 1,569,850 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $11.4M | 0.67% | 1,660,763 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $11.3M | 0.67% | 261,803 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $10.1M | 0.59% | 411,728 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $8.0M | 0.47% | 2,074,350 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $7.0M | 0.41% | 3,836,576 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $6.9M | 0.41% | 3,031,009 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $6.7M | 0.39% | 1,383,366 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $6.7M | 0.39% | 1,942,555 | Common | SOLE |
| H00263105 | ACIU | AC IMMUNE SA | $6.4M | 0.38% | 1,694,167 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $5.1M | 0.30% | 97,116 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $4.6M | 0.27% | 2,107,215 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $4.3M | 0.25% | 2,108,219 | Common | SOLE |
| 046513206 | ATRA | ATARA BIOTHERAPEUTICS INC | $3.7M | 0.22% | 452,270 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $3.6M | 0.21% | 1,023,548 | Common | SOLE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $3.4M | 0.20% | 2,074,372 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $3.4M | 0.20% | 310,884 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $3.1M | 0.18% | 3,065,714 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $3.0M | 0.18% | 1,046,587 | Common | SOLE |
| 39868T105 | 2JQ | GRITSTONE BIO INC | $2.9M | 0.17% | 4,920,178 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $2.7M | 0.16% | 13,847 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $2.1M | 0.12% | 442,826 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $2.0M | 0.12% | 3,077,828 | Common | SOLE |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $1.6M | 0.10% | 1,608,089 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $1.5M | 0.09% | 1,907,969 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $1.0M | 0.06% | 504,532 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $680,113 | 0.04% | 715,607 | Common | SOLE |
| 43906K209 | HOOK | HOOKIPA PHARMA INC | $457,417 | 0.03% | 106,376 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.